Serum HE4 and Diagnosis of Ovarian Cancer in Postmenopausal Women With Adnexal Masses

American Journal of Obstetrics and Gynecology - United States
doi 10.1016/j.ajog.2019.07.031
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Effects of Personal Characteristics on Serum CA125, Mesothelin, and HE4 Levels in Healthy Postmenopausal Women at High-Risk for Ovarian Cancer

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2008English

Diagnostic Performance of Serum Human Epididymis Protein 4 (HE4) for Prediction of Malignancy in Ovarian Masses

Asian Pacific Journal of Cancer Prevention
2019English

Serum HE4 Levels Combined With CE CT Imaging Improve the Management of Monitoring Women Affected by Epithelial Ovarian Cancer

Oncology Reports
MedicineCancer ResearchOncology
2013English

Biomarkers and Algorithms for Diagnosis of Ovarian Cancer: CA125, HE4, RMI and ROMA, a Review

Journal of Ovarian Research
GynecologyOncologyObstetrics
2019English

The Use of HE4, CA125 and CA72-4 Biomarkers for Differential Diagnosis Between Ovarian Endometrioma and Epithelial Ovarian Cancer

Journal of Ovarian Research
GynecologyOncologyObstetrics
2013English

Preoperative Evaluation of Doppler Ultrasound Indices in Postmenopausal Ovarian Masses

SiSli Etfal Hastanesi Tip Bulteni / The Medical Bulletin of Sisli Hospital
2014English

Serum Estrogen Receptor Bioactivity and Breast Cancer Risk Among Postmenopausal Women

Endocrine-Related Cancer
Cancer ResearchEndocrinologyOncologyMetabolismDiabetes
2013English

MRI of Adnexal Masses in Pregnancy

American Journal of Roentgenology
MedicineNuclear MedicineRadiologyImaging
2008English

Serum Folate Receptor Α (sFR) in Ovarian Cancer Diagnosis and Surveillance

Cancer Medicine
Cancer ResearchNuclear MedicineRadiologyImagingOncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy